By 2025, cumulative global mRNA vaccine vaccinations have exceeded 10 billion doses, and their efficacy and safety have completely rewritten the landscape of infectious disease prevention and control. From COVID-19 vaccines toRead More…
In recent years, mRNA therapy has emerged as a groundbreaking field in medicine, holding the promise to transform the way we treat a wide range of diseases. This blog post will exploreRead More…
The world witnessed the rapid development and remarkable efficacy of messenger RNA (mRNA) vaccines against the COVID-19 pandemic, highlighting the immense potential of this technology beyond infectious diseases. The focus is nowRead More…
RNA-protein interactions (RPIs) are central to cellular function, governing processes such as mRNA splicing, translation regulation, and RNA degradation. Dysregulation of these interactions is implicated in diseases ranging from cancer to neurodegenerativeRead More…
Advanced delivery systems that overcome biological barriers while maintaining safety and efficacy are essential for the success of mRNA-based therapies. Creative Biolabs integrate recent advancements and challenges facing mRNA delivery systems intoRead More…
Introduction mRNA is the interlocutor between the genetic code and the protein machine that powers life, part of the dance of molecular biology. The molecule is recently a superstar in the creationRead More…
In life’s circuits, message RNA (mRNA) sits between genetic material and protein synthesis, slipping from DNA to proteins. That’s transcription: the making of mRNA — the job that’s vital for gene expression,Read More…
What’s the Next Frontier in Medicine? These last couple of years, mRNA therapies have been a long-running great medical development, along with super-fast COVID-19 vaccines. These vaccines already demonstrated what mRNA can do,Read More…
Niren Murthy of the University of California, Berkeley, Wang Aijun of the University of California, Davis, and others published a research paper titled: Acid-degradable lipid nanoparticles enhance the delivery of mRNA in the Nature sub-journalRead More…
mRNA-4157 (V940) is a personalized tumor mRNA vaccine. By utilizing lipid nanoencapsulation technology, mRNA-4157 can deliver up to 34 tumor-specific antigens (also called tumor neoantigens) that are specifically tailored for tumor patients into theRead More…